🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial aims to characterise the pharmacokinetic (PK) profile and estima...
Status
Completed
Location
Richmond Pharmacology Limited
Start Date
2021-11-17
Trial ID
NCT04866602
The aim of this study is to evaluate the influence of tegoprazan on the pha...
Status
Completed
Location
Seoul National University Hospital, Clinical Trial Center
Start Date
2020-11-25
Trial ID
NCT04568772
Treatments Being Tested
To facilitate provision of atovaquone (566C80) to patients who have mild to...
Status
Completed
Location
Glaxo Wellcome Inc
Start Date
TBD
Trial ID
NCT00001991
Treatments Being Tested
BRIEF SUMMARY Canadians often visit areas with malaria where the preventat...
Status
Unknown
Location
National Capital Region Occupational Health Clinic
Start Date
2014-01
Trial ID
NCT01976325
Treatments Being Tested
To facilitate provision of atovaquone (566C80) to patients who have severe ...
Status
Completed
Location
Glaxo Wellcome Inc
Start Date
TBD
Trial ID
NCT00001990
Treatments Being Tested
Malaria, a disease caused by the parasite Plasmodium, is one of the world's...
Status
Completed
Location
Radboud university medical center
Start Date
2014-06
Trial ID
NCT02080026
Treatments Being Tested
The aim of the study is to determine the tolerability and safety of ATV-PG ...
Status
Completed
Location
Richmond Pharmacology Ltd.
Start Date
2019-04-04
Trial ID
NCT04002687
Treatments Being Tested
To compare the safety of atovaquone (566C80) with intravenous (IV) pentamid...
Status
Completed
Location
East Bay AIDS Ctr
Start Date
TBD
Trial ID
NCT00001996
Treatments Being Tested
This is an exploratory trial to evaluate the effect of antimalarial drugs o...
Status
Completed
Location
State University of New York, Upstate Medical University (SUNY-UMU)
Start Date
2016-11-11
Trial ID
NCT02564471
Treatments Being Tested
This study evaluates the efficacy and safety of a single dose of M5717 plus...
Status
Completed
Location
Groupe de Recherche Action en Sante (GRAS)
Start Date
2023-11-28
Trial ID
NCT05974267
Treatments Being Tested